Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (R43/R44)
ArchivedNational Institutes of Health
Description
This Funding Opportunity Announcement (FOA) solicits Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) to develop point-of-care or benchtop instruments, or other laboratory-based approaches for the characterization of major classes of analytes that include known and suspected toxicants and their major metabolites in human biological samples, including blood, urine, and saliva, which are likely to be available from both prospective and retrospective epidemiological cohorts. The focus of technology development is on the ability to detect multiple chemical analytes with high sensitivity and specificity in low volumes of biological specimens.
Who can apply
- Small businesses
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedMay 9, 2014
- ClosesAug 15, 2014
- Program funding$3,000,000
- CFDA93.113
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro